The results showed that 11 of 11 malignant ovarian tumors displayed moderate to strong nuclear, cytoplasmic, and membrane immunoreactivity positivity of ACTL6A protein (Figure 4D). This evidence concerns the gene ACTL6A and ovarian neoplasm.